Every Form 4 that OmniAb, Inc. Warrant (OABIW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow OABIW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OABIW filings page.
OmniAb, Inc. granted its Chief Operating Officer, Nwachuku Amechi Ekeke, a stock option covering 800,000 shares of common stock at a $1.9800 per-share exercise price, expiring on August 1, 2036. The option vests as to 1/8 of the shares on the six-month anniversary of the grant date and as to 1/48 of the shares each month thereafter for 42 months, beginning on August 1, 2026, subject to his continued service.
OmniAb director Carolyn R. Bertozzi reported equity-based compensation activity. She exercised 20,000 Restricted Stock Units into Common Stock, bringing her direct holdings to 113,308 shares. She also received grants of 40,000 stock options at an exercise price of $2.03 and 20,000 new RSUs, each unit representing one share of Common Stock. The RSUs and options vest in full on the earlier of the next annual stockholder meeting or the first anniversary of their grant date.
OmniAb director Jennifer R. Cochran reported equity compensation-related transactions. On June 17, 20,000 Restricted Stock Units vested and were converted into 20,000 shares of Common Stock, bringing her direct holdings to 185,274 shares. She also received 40,000 stock options with a $2.03 exercise price and 20,000 new RSUs, each tied to one share of Common Stock, all vesting in full on the earlier of the next annual stockholder meeting or the first anniversary of the grant date.
OmniAb, Inc. director Steven C. Crouse reported equity compensation-related transactions with no share sales. He exercised derivative rights to acquire 20,000 shares of Common Stock, bringing his direct holdings to 33,333 shares. He also received 40,000 stock options at a $2.03 exercise price and 20,000 Restricted Stock Units, which vest based on the next annual stockholder meeting or the first anniversary of grant.
OmniAb director Philip J. Gotwals reported equity compensation and vesting activity. He acquired 20,000 shares of Common Stock through the vesting and conversion of previously granted Restricted Stock Units and now holds 33,333 shares directly. He also received 40,000 new stock options with a $2.03 exercise price and 20,000 new RSUs, which vest in full on the earlier of the next annual stockholder meeting or the first anniversary of their grant dates.
OmniAb, Inc. director John L. Higgins reported compensation-related equity activity with no open-market trades. On June 17, 2026, he exercised 20,000 Restricted Stock Units into Common Stock, bringing his direct holdings to 2,962,320 shares. He also received 40,000 stock options at an exercise price of $2.03 per share, expiring on June 17, 2036, and a new grant of 20,000 RSUs, which vest in full on the earlier of the next annual stockholder meeting or the first anniversary of their grant.
OmniAb, Inc. director Steven Love reported equity compensation transactions and an option-related share acquisition. On June 17, 2026, he acquired 20,000 shares of Common Stock through the exercise or conversion of a derivative security, bringing his direct Common Stock holdings to 91,666 shares.
On the same date, he received a grant of 40,000 Stock Options with an exercise price of $2.03 per share, exercisable for Common Stock until June 17, 2036. He also received 20,000 Restricted Stock Units, each representing one share of Common Stock, and 20,000 RSUs vested into shares, leaving 13,334 RSUs outstanding. All activity reflects awards, vesting, and exercises; no open‑market purchases or sales were reported.
OmniAb, Inc. director Philip J. Gotwals reported an exercise of restricted stock units into common shares. On April 21, 2026, 13,333 Restricted Stock Units converted into 13,333 shares of Common Stock at a stated price of $0.0000 per share.
Following the transaction, he directly holds 13,333 shares of Common Stock and 46,667 Restricted Stock Units. The RSUs vest in three substantially equal annual installments beginning April 21, 2026, subject to his continued service with OmniAb through each vesting date.
OmniAb, Inc. director Steven C. Crouse acquired 13,333 shares of Common Stock through the exercise of Restricted Stock Units at a stated price of $0.00 per share. Following the transaction, he directly holds 13,333 Common shares and 46,667 Restricted Stock Units.
The 13,333 Restricted Stock Units referenced in the filing vest in three substantially equal annual installments beginning on April 21, 2026, subject to Crouse’s continued service. Each Restricted Stock Unit represents a contingent right to receive one share of OmniAb’s Common Stock.
OmniAb, Inc. President and CEO Matthew W. Foehr reported routine equity compensation activity. On April 7, 2026, 36,459 Restricted Stock Units vested and were converted into the same number of OmniAb common shares at no exercise price. To satisfy tax withholding obligations tied to this vesting, 19,244 shares of common stock were sold in mandated “sell-to-cover” transactions at a weighted average price of $1.49 per share, rather than at Foehr’s discretion. Following these transactions, Foehr directly holds 4,420,492 shares of OmniAb common stock and 309,376 RSUs, indicating that the sale represents a small portion of his overall equity position.
OmniAb, Inc. Executive VP, Finance and CFO Kurt A. Gustafson reported routine equity compensation activity. On April 7, 2026, 13,542 Restricted Stock Units vested, converting into the same number of common shares at no cost. To cover tax withholding on this vesting, 6,913 common shares were sold in a mandated sell-to-cover transaction at a weighted average price of $1.49 per share, rather than as a discretionary sale. After these events, he directly holds 261,483 shares of OmniAb common stock, reflecting prior transfers including 13,997 shares delivered to an ex-spouse under a domestic relations order.
OmniAb, Inc. Chief Legal Officer Charles S. Berkman reported routine equity compensation activity. On April 7, 2026, 13,542 Restricted Stock Units vested, converting into the same number of common shares at no exercise price. To satisfy tax withholding obligations under OmniAb’s equity incentive plans, 7,157 common shares were sold in a mandated “sell-to-cover” transaction at a weighted-average price of $1.49 per share, rather than as a discretionary trade. Following these transactions, Berkman directly holds 399,085 shares of OmniAb common stock and 111,042 RSUs, indicating that only a small portion of his position was sold.
OmniAb, Inc. Chief Legal Officer Charles S. Berkman reported multiple equity compensation moves and a small mandated share sale. He acquired 18,750 shares of common stock through the vesting and conversion of Restricted Stock Units (RSUs), and was granted 60,000 new RSUs and 600,000 stock options, all held directly.
To cover tax withholding on the RSU vesting, 9,673 common shares were sold in a required "sell-to-cover" transaction at a weighted average price of $1.71, with individual trades between $1.68 and $1.73. After these transactions, he directly owned 392,700 shares of common stock, 124,584 RSUs and 600,000 stock options.
OmniAb, Inc. Executive VP, Finance and CFO Kurt A. Gustafson reported multiple equity transactions. He acquired 18,750 shares of common stock through the vesting and conversion of restricted stock units and received new awards of 60,000 RSUs and stock options for 600,000 shares.
Following these awards, he sold 9,301 shares of common stock at a weighted average price of $1.71 per share to cover tax withholding obligations under a mandatory sell-to-cover arrangement, which the company’s equity plans require rather than a discretionary trade.
OmniAb, Inc. President and CEO Matthew W. Foehr reported multiple equity transactions on February 18, 2026. He acquired 58,333 shares of common stock through the vesting and exercise of restricted stock units (RSUs) and received new awards of 156,250 RSUs and 1,562,500 stock options.
The vested RSUs represent a grant that vests in three substantially equal annual installments beginning on February 18, 2026, while the new RSU grant vests in three substantially equal annual installments beginning on February 18, 2027. The stock option grant becomes exercisable as to 12.5% of the underlying shares six months after the grant date, then in 42 substantially equal monthly installments.
To cover tax withholding obligations from the RSU vesting, 30,843 shares of common stock were sold at a weighted average price of $1.71 per share in transactions priced between $1.68 and $1.73. The filing states these are mandatory sell-to-cover transactions under the company’s equity incentive plans and not discretionary trades.
FOEHR MATTHEW W reported multiple insider transaction types in a Form 4 filing for OABI. The filing lists transactions totaling 93,670 shares at a weighted average price of $1.70 per share. Following the reported transactions, holdings were 4,375,787 shares.
GUSTAFSON KURT A reported multiple insider transaction types in a Form 4 filing for OABI. The filing lists transactions totaling 33,912 shares at a weighted average price of $1.70 per share. Following the reported transactions, holdings were 259,402 shares.
Berkman Charles S reported multiple insider transaction types in a Form 4 filing for OABI. The filing lists transactions totaling 34,074 shares at a weighted average price of $1.70 per share. Following the reported transactions, holdings were 383,623 shares.
OmniAb, Inc. director John L. Higgins reported the vesting of 13,172 restricted stock units (RSUs) and the corresponding acquisition of 13,172 shares of common stock on January 30, 2026.
The RSUs vest in three substantially equal annual installments beginning January 30, 2024, conditioned on his continued service. After this transaction, he beneficially owns 2,942,320 shares of common stock and 20,000 RSUs directly.